As of July 2026, 31 paid clinical trials are recruiting for Oncology in Torrance, California. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Torrance has approximately 185 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Researchers run research studies in Torrance, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Torrance Memorial Physician Network - Cancer Care | Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 22 |
| City of Hope South Bay | Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain | 18 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Atherosclerosis, Chronic Limb-Threatening Ischemia, Recurrent B Acute Lymphoblastic Leukemia | 16 |
| Torrance Memorial Medical Center | AMI Cardiogenic Shock, Acute Myocardial Infarction (AMI), Aortic Stenosis | 8 |
| Harbor-UCLA Medical Center | Diabetes Mellitus, Type 1, End-Stage Renal Disease, Heart Failure | 5 |
| Neurocrine Clinical Site | Schizophrenia, Tardive Dyskinesia | 4 |
| The Lundquist Institute | ASCVD, ASCVD Management, Atherosclerosis Cardiovascular Disease | 4 |
| Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center | Acute Myocardial Infarction, Diabetes Mellitus, Type 2, Heart Failure | 4 |
| Collaborative Neuroscience Research, LLC | Bipolar Disorder Type I With Mania, Bipolar Disorder Type I With Mania or Mania With Mixed Features, Schizophrenia | 3 |
| Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center | Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities, Moderate Aortic Valve Stenosis, Peripheral Arterial Disease | 3 |
| The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 3 |
| Breathe Clear Institute | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Chronic Rhinosinusitis Without Nasal Polyps | 2 |
| CS Cancer at the Hunt Cancer Center | Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Carcinoma | 2 |
| City of Hope at South Bay | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 2 |
| GSK Investigational Site | Multiple Myeloma, Neoplasms, Head and Neck | 2 |
| Harbor UCLA Medical Center | Hypertension, Ketamine Infusion, Myocardial Infarction | 2 |
| Hunt Cancer Institute, an Affiliate of CS Cancer | Early Stage Triple-Negative Breast Carcinoma, TNBC, TNBC - Triple-Negative Breast Cancer | 2 |
| Local Institution - 1639 | Alzheimer Disease, Agitation | 2 |
| Lundquist Inst BioMed at Harbor | Chronic Myelogenous Leukemia - Chronic Phase, Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors | 2 |
| Macula Retina Vitreous Research Institute | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Neovascular Age-related Macular Degeneration | 2 |
| Retina Macula Institute | Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Macular Degeneration | 2 |
| The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente | B-Cell Non-Hodgkins Lymphoma, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | 2 |
| Torrance Memorial Physicians Network | Colorectal Neoplasms | 2 |
| UCLA Hematology/Oncology - Torrance | Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC) | 2 |
| Genesis Research LLC | Non-muscle Invasive Bladder Cancer, Carcinoma in Situ, Non-Muscle Invasive Bladder Neoplasms | 2 |
Recruiting trials in Torrance grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Hipa.ai aggregates every recruiting study in Torrance from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 185 recruiting clinical trials in Torrance, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Torrance compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Torrance include Breast Cancer (6), Schizophrenia (6), Anatomic Stage II Breast Cancer AJCC v8 (5), Stage IV Lung Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Torrance on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Torrance include Torrance Memorial Physician Network - Cancer Care, City of Hope South Bay, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Torrance are Cancer & tumors (63), Cardiovascular (16), Mental health & behavior (11). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.